MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)

NACompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Hypertension, Portal
Interventions
PROCEDURE

Transjugular HVPG measurement

By means of catheterization of a hepatic vein with a balloon catheter.

PROCEDURE

MR imaging

MR images for the post-processing analysis

Trial Locations (11)

Unknown

Beijing 302 Hospital, Beijing

The First Hospital of Lanzhou University, Lanzhou

Nanfang Hospital of Southern Medical University, Guangzhou

Shunde Hospital, Southern Medical University, Shunde

Xingtai People's Hospital, Xingtai

The First Hospital of Zhengzhou University, Zhengzhou

Zhongda Hospital, Medical School of Southeast University, Nanjing

Shandong Provincial Hospital affiliated to Shandong University, Jinan

Shanghai Public Health Clinical Center, Fudan University, Shanghai

Affiliated Lishui Hospital of Zhejiang University, Lishui

Ankara University School of Medicine, Ankara

All Listed Sponsors
collaborator

Zhongda Hospital

OTHER

collaborator

Beijing 302 Hospital

OTHER

collaborator

Affiliated Lishui Hospital of Zhejiang University

UNKNOWN

collaborator

Shandong Provincial Hospital

OTHER_GOV

collaborator

Xingtai People's Hospital

OTHER

collaborator

The First Hospital of Zhengzhou University

UNKNOWN

collaborator

Shanghai Public Health Clinical Center, Fudan University

UNKNOWN

collaborator

LanZhou University

OTHER

collaborator

Southern Medical University, China

OTHER

collaborator

Ankara University

OTHER

lead

Nanfang Hospital, Southern Medical University

OTHER

NCT03766880 - MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802) | Biotech Hunter | Biotech Hunter